User menu

Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.

Bibliographic reference Roux, C ; Reid, D M ; Devogelaer, Jean-Pierre ; Saag, K ; Lau, C S ; et. al. Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.. In: Osteoporosis International : with other metabolic bone diseases, Vol. 23, no. 3, p. 1083-90 (2012)
Permanent URL
  1. Devogelaer Jean-Pierre, Goemaere Stefan, Boonen Steven, Body Jean-Jacques, Kaufman Jean-Marc, Reginster Jean-Yves, Rozenberg Serge, Boutsen Yves, Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club, 10.1007/s00198-005-2032-z
  2. , Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update, 10.1002/1529-0131(200107)44:7<1496::aid-art271>;2-5
  3. Caplan Liron, Saag Kenneth G, Glucocorticoids and the risk of osteoporosis, 10.1517/14740330802648194
  4. Sambrook P N, Osteocyte viability with glucocorticoid treatment: relation to histomorphometry, 10.1136/ard.2003.008839
  5. Benvenuti S, Brandi ML (2000) Corticosteroid-induced osteoporosis: pathogenesis and prevention. Clin Exp Rheumatol 18:S64–S66
  6. Roux C (2010) Osteoporosis in inflammatory joint diseases. Osteoporos Int. doi: 10.1007/s00198-010-1319-x
  7. Silverman Stuart L., Lane Nancy E., Glucocorticoid-induced osteoporosis, 10.1007/s11914-009-0005-4
  8. Miller Paul D., Anti-resorptives in the management of osteoporosis, 10.1016/j.beem.2008.07.004
  9. Plotkin Lilian I., Manolagas Stavros C., Bellido Teresita, Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs, 10.1016/j.bone.2006.02.060
  10. Russell R. G. G., Watts N. B., Ebetino F. H., Rogers M. J., Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy, 10.1007/s00198-007-0540-8
  11. Saag Kenneth G., Emkey Ronald, Schnitzer Thomas J., Brown Jacques P., Hawkins Federico, Goemaere Stefan, Thamsborg Gorm, Liberman Uri A., Delmas Pierre D., Malice Marie-Pierre, Czachur Michelle, Daifotis Anastasia G., Lane Nancy, Correa-Rotter Ricardo, Yanover Melissa, Westhovens Rene, Epstein Sol, Adachi Jonathan D., Poubelle Patrice, Melo-Gomes Jose, Rodriguez-Portales Jose A., Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis, 10.1056/nejm199807303390502
  12. Reid David M., Hughes Rodney A., Laan Roland F. J. M., Sacco-Gibson Nancy A., Wenderoth Dietrich H., Adami Silvano, Eusebio Rachelle A., Devogelaer Jean-Pierre, Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial, 10.1359/jbmr.2000.15.6.1006
  13. Cohen Stanley, Levy Robert M., Keller Michael, Boling Eugene, Emkey Ronald D., Greenwald Maria, Zizic Thomas M., Wallach Stanley, Sewell Kathryn L., Lukert Barbara P., Axelrod Douglas W., Chines Arkadi A., Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, 10.1002/1529-0131(199911)42:11<2309::aid-anr8>;2-k
  14. Roux C., Randomized Trial of Effect of Cyclical Etidronate in the Prevention of Corticosteroid-Induced Bone Loss, 10.1210/jc.83.4.1128
  15. Adachi Jonathan D., Saag Kenneth G., Delmas Pierre D., Liberman Uri A., Emkey Ronald D., Seeman Ego, Lane Nancy E., Kaufman Jean-Marc, Poubelle Patrice E. E., Hawkins Federico, Correa-Rotter Ricardo, Menkes Charles-Joel, Rodriguez-Portales Jose A., Schnitzer Thomas J., Block Joel A., Wing Jeffrey, McIlwain Harris H., Westhovens Rene, Brown Jacques, Melo-Gomes Jose A., Gruber Barry L., Yanover Melissa J., Leite Maria Odette R., Siminoski Kerry G., Nevitt Michael C., Sharp John T., Malice Marie-Pierre, Dumortier Thomas, Czachur Michelle, Carofano Wendy, Daifotis Anastasia, Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial, 10.1002/1529-0131(200101)44:1<202::aid-anr27>;2-w
  16. Wallach S., Cohen S., Reid D. M., Hughes R. A., Hosking D. J., Laan R. F., Doherty S. M., Maricic M., Rosen C., Brown J., Barton I., Chines A. A., Effects of Risedronate Treatment on Bone Density and Vertebral Fracture in Patients on Corticosteroid Therapy, 10.1007/s002230001146
  17. Iwamoto Jun, Takeda Tsuyoshi, Sato Yoshihiro, Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis – usefulness of alendronate and risedronate, 10.1517/14656566.8.16.2743
  18. Boonen S., Vanderschueren D., Venken K., Milisen K., Delforge M., Haentjens P., Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance, 10.1111/j.1365-2796.2008.02010.x
  19. Compston Juliet, Management of glucocorticoid-induced osteoporosis, 10.1038/nrrheum.2009.259
  20. Black Dennis M., Delmas Pierre D., Eastell Richard, Reid Ian R., Boonen Steven, Cauley Jane A., Cosman Felicia, Lakatos Péter, Leung Ping Chung, Man Zulema, Mautalen Carlos, Mesenbrink Peter, Hu Huilin, Caminis John, Tong Karen, Rosario-Jansen Theresa, Krasnow Joel, Hue Trisha F., Sellmeyer Deborah, Eriksen Erik Fink, Cummings Steven R., Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis, 10.1056/nejmoa067312
  21. Lyles Kenneth W., Colón-Emeric Cathleen S., Magaziner Jay S., Adachi Jonathan D., Pieper Carl F., Mautalen Carlos, Hyldstrup Lars, Recknor Chris, Nordsletten Lars, Moore Kathy A., Lavecchia Catherine, Zhang Jie, Mesenbrink Peter, Hodgson Patricia K., Abrams Ken, Orloff John J., Horowitz Zebulun, Eriksen Erik Fink, Boonen Steven, Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture, 10.1056/nejmoa074941
  22. Reid David M, Devogelaer Jean-Pierre, Saag Kenneth, Roux Christian, Lau Chak-Sing, Reginster Jean-Yves, Papanastasiou Philemon, Ferreira Alberto, Hartl Florian, Fashola Taiwo, Mesenbrink Peter, Sambrook Philip N, Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial, 10.1016/s0140-6736(09)60250-6
  23. Yeap S. S., Management of corticosteroid-induced osteoporosis, 10.1093/rheumatology/41.10.1088
  24. Cockcroft Donald W., Gault Henry, Prediction of Creatinine Clearance from Serum Creatinine, 10.1159/000180580
  25. Van Staa T. P., Laan R. F., Barton I. P., Cohen S., Reid D. M., Cooper C., Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy, 10.1002/art.11283
  26. Naganathan Vasi, Jones Graeme, Nash Peter, Nicholson Geoff, Eisman John, Sambrook Philip N., Vertebral Fracture Risk With Long-term Corticosteroid Therapy : Prevalence and Relation to Age, Bone Density, and Corticosteroid Use, 10.1001/archinte.160.19.2917
  27. Jamal Sophie A., Swan Victoria J.D., Brown Jacques P., Hanley David A., Prior Jerilynn C., Papaioannou Alexandra, Langsetmo Lisa, Josse Robert G., RETRACTED: Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study, 10.1053/j.ajkd.2009.10.049
  28. Tucci Marco, Stucci Stefania, Strippoli Sabino, Silvestris Francesco, Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus, 10.1155/2010/457146
  29. Pecora Patricia G, Kaplan Barbara, Corticosteroids and Ulcers: Is There an Association?, 10.1177/106002809603000729
  30. Targownik L. E., Lix L. M., Metge C. J., Prior H. J., Leung S., Leslie W. D., Use of proton pump inhibitors and risk of osteoporosis-related fractures, 10.1503/cmaj.071330
  31. Roux Christian, Briot Karine, Gossec Laure, Kolta Sami, Blenk Tilo, Felsenberg Dieter, Reid David M., Eastell Richard, Glüer Claus C., Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole, 10.1007/s00223-008-9188-4